The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Co–Ferrocene MOF/Glucose Oxidase as Cascade Nanozyme for Effective Tumor Therapy
Abstract
Chemodynamic therapy (CDT), enabling selective therapeutic effects and low side effect, attracts increasing attention in recent years. However, limited intracellular content of H 2 O 2 and acid at the tumor site restrains the lasting Fenton reaction and thus the anticancer efficacy of CDT. Herein, a nanoscale Co–ferrocene metal–organic framework (Co‐Fc NMOF) with high Fenton activity is synthesized and combined with glucose oxidase (GOx) to construct a cascade enzymatic/Fenton catalytic platform (Co‐Fc@GOx) for enhanced tumor treatment. In this system, Co‐Fc NMOF not only acts as a versatile and effective delivery cargo of GOx molecules to modulate the reaction conditions, but also possesses excellent Fenton effect for the generation of highly toxic •OH. In the tumor microenvironment, GOx delivered by Co‐Fc NMOF catalyzes endogenous glucose to gluconic acid and H 2 O 2. The intracellular acidity and the on‐site content of H 2 O 2 are consequently promoted, which in turn favors the Fenton reaction of Co‐Fc NMOF and enhances the generation of reactive oxygen species (ROS). Both in vitro and in vivo results demonstrate that this cascade enzymatic/Fenton catalytic reaction triggered by Co‐Fc@GOx nanozyme enables remarkable anticancer properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Tang, F., Li, L., & Chen, D. (2012) · Advanced Materials · doi:10.1002/adma.201104763 · Cited by 2,836
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy
Wu, M., & Yang, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606134 · Cited by 2,285
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
Tang, Z., Liu, Y., He, M., & Bu, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201805664 · Cited by 1,951
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,513
Supramolecular Chemistry on Water-Soluble Carbon Nanotubes for Drug Loading and Delivery
Liu, Z., Sun, X., Nakayama-Ratchford, N., & Dai, H. (2007) · ACS Nano · doi:10.1021/nn700040t · Cited by 1,368
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Huo, M., Wang, L., Chen, Y., & Shi, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00424-8 · Cited by 1,322
Zhang, C., Bu, W., Ni, D., Zhang, S., Li, Q., Yao, Z., Zhang, J., Yao, H., Wang, Z., & Shi, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510031 · Cited by 1,269
Bankar, S. B., Bule, M. V., Singhal, R. S., & Ananthanarayan, L. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.04.003 · Cited by 1,253
A Luminescent Microporous Metal−Organic Framework for the Recognition and Sensing of Anions
Chen, B., Wang, L., Zapata, F., Qian, G., & Lobkovsky, E. B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802035e · Cited by 1,014
Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy
Lin, H., Chen, Y., & Shi, J. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00471k · Cited by 803
Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment
Fu, L.-H., Qi, C., Lin, J., & Huang, P. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00891k · Cited by 783
Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649
Recent Progress in Electrically Rechargeable Zinc–Air Batteries
Fu, J., Liang, R., Liu, G., Yu, A., Bai, Z., Yang, L., & Chen, Z. (2019) · Advanced Materials · doi:10.1002/adma.201805230 · Cited by 591
Zhang, L., Wan, S.-S., Li, C.-X., Xu, L., Cheng, H., & Zhang, X.-Z. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03178 · Cited by 584
Ferrocifen type anti cancer drugs
Jaouen, G., Vessières, A., & Top, S. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00486a · Cited by 581
Glucose oxidase: natural occurrence, function, properties and industrial applications
Wong, C. M., Wong, K. H., & Chen, X. D. (2008) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1407-4 · Cited by 553
The role of metal–organic frameworks in a carbon-neutral energy cycle
Schoedel, A., Ji, Z., & Yaghi, O. M. (2016) · Nature Energy · doi:10.1038/nenergy.2016.34 · Cited by 516
Application of ferrocene and its derivatives in cancer research
Ornelas, C. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20172g · Cited by 473
Nanoscale metal−organic frameworks for combined photodynamic & radiation therapy in cancer treatment
Liu, J., Yang, Y., Zhu, W., Yi, X., Dong, Z., Xu, X., Chen, M., Yang, K., Lu, G., Jiang, L., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.034 · Cited by 447
Albain, K. S., Nag, S. M., Calderillo-Ruiz, G., Jordaan, J. P., Llombart, A. C., Pluzanska, A., Rolski, J., Melemed, A. S., Reyes-Vidal, J. M., Sekhon, J. S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9362 · Cited by 425
Yang, Y., Liu, J., Liang, C., Feng, L., Fu, T., Dong, Z., Chao, Y., Li, Y., Lu, G., Chen, M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07882 · Cited by 342
Programmable Kiri‐Kirigami Metamaterials
Tang, Y., Lin, G., Yang, S., Yi, Y. K., Kamien, R. D., & Yin, J. (2017) · Advanced Materials · doi:10.1002/adma.201604262 · Cited by 298
Hu, P., Wu, T., Fan, W., Chen, L., Liu, Y., Ni, D., Bu, W., & Shi, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.06.035 · Cited by 266
Ray Chowdhuri, A., Bhattacharya, D., & Sahu, S. K. (2016) · Dalton Transactions · doi:10.1039/c5dt03736k · Cited by 253
Wang, D., Zhou, J., Chen, R., Shi, R., Xia, G., Zhou, S., Liu, Z., Zhang, N., Wang, H., Guo, Z., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.039 · Cited by 239
Iron and Reactive Oxygen Species: Friends or Foes of Cancer Cells?
Bystrom, L. M., Guzman, M. L., & Rivella, S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5014 · Cited by 212
Wang, L., Huo, M., Chen, Y., & Shi, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.018 · Cited by 181
Wang, Y., Shi, L., Ye, Z., Guan, K., Teng, L., Wu, J., Yin, X., Song, G., & Zhang, X.-B. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b03556 · Cited by 159
Xue, T., Xu, C., Wang, Y., Wang, Y., Tian, H., & Zhang, Y. (2019) · Biomaterials Science · doi:10.1039/c9bm01044k · Cited by 157
Yin, X., Zhou, J., Song, Z., Dong, Z., Bao, Q., Shrestha, N., Bista, S. S., Ellingson, R. J., Yan, Y., & Tang, W. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201904300 · Cited by 142
Liu, Z., Li, T., Han, F., Wang, Y., Gan, Y., Shi, J., Wang, T., Akhtar, M. L., & Li, Y. (2019) · Biomaterials Science · doi:10.1039/c9bm00641a · Cited by 110
Overcoming limitations of natural anticancer drugs by combining with artificial agents
Blagosklonny, M. V. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.002 · Cited by 99
Zhang, Y., Lin, L., Liu, L., Liu, F., Shu, S., Tian, H., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119255 · Cited by 96
Yao, Z., Zhang, B., Liang, T., Ding, J., Min, Q., & Zhu, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b06034 · Cited by 89
Yin, B., Wang, Y., Zhang, C., Zhao, Y., Wang, Y., Teng, L., Yang, Y., Zeng, Z., Huan, S., Song, G., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04429 · Cited by 34
Cited by
Fu, L., Wan, Y., Qi, C., He, J., Li, C., Yang, C., Xu, H., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202006892 · Cited by 820
Biomedicine Meets Fenton Chemistry
Tang, Z., Zhao, P., Wang, H., Liu, Y., & Bu, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00977 · Cited by 745
Chemodynamic Therapy via Fenton and Fenton‐Like Nanomaterials: Strategies and Recent Advances
Jia, C., Guo, Y., & Wu, F. (2022) · Small · doi:10.1002/smll.202103868 · Cited by 685
Recent Advances in Nanozymes: From Matters to Bioapplications
Ai, Y., Hu, Z., Liang, X., Sun, H., Xin, H., & Liang, Q. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202110432 · Cited by 534
Zhou, Y., Fan, S., Feng, L., Huang, X., & Chen, X. (2021) · Advanced Materials · doi:10.1002/adma.202104223 · Cited by 463
Metadata
- Authors
- Fang, C., Deng, Z., Cao, G., Chu, Q., Wu, Y., Li, X., Peng, X., & Han, G.
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2020-02-24
- Volume
- 30
- Issue
- 16
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- OpenAlex
- W3008745391
- Cited by
- 423
- References
- 39
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.